Viewing Study NCT05907512


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2025-12-26 @ 11:12 PM
Study NCT ID: NCT05907512
Status: UNKNOWN
Last Update Posted: 2023-06-22
First Post: 2023-06-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module